Table 1. EGFR-directed monoclonal antibodies.
| Monoclonal antibodies | Clinical status |
|---|---|
| Cetuximab | Phase III, approval pending |
| Necitumumab | Phase III |
| Matuzumab | Phase II |
| Panitumumab | Phase II |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.